Andreas von Deimling

Tumor heterogeneity and tumor-microglia interactions in primary and recurrent IDH1-mutant gliomas

M. Rehli, Julian Taranda, P. L. Poliani, 2023, Cell reports. Medicine.

Dedifferentiated and undifferentiated ovarian carcinoma: an aggressive and molecularly distinct ovarian tumor characterized by frequent SWI/SNF complex inactivation

M. Köbel, B. Tessier-Cloutier, Jennifer Pors, 2023, Modern Pathology.

Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation

M. Bockmayr, G. Nagae, K. Tatsuno, 2024, Acta neuropathologica.

Analyses of combined Merkel cell carcinomas with neuroblastic components suggests that loss of T antigen expression in Merkel cell carcinoma may result in cell cycle arrest and neuroblastic transdifferentiation.

D. Schrama, R. Houben, S. Appenzeller, 2024, The Journal of pathology.

Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma

M. Hentze, O. Myklebost, L. Meza-Zepeda, 2024, Nature communications.

Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis

A. Wick, T. Kessler, T. Eichkorn, 2024, Journal of neuro-oncology.

Mapping of the chromosome 19 q‐arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

B. Scheithauer, D. Louis, H. Mohrenweiser, 2000, Genes, chromosomes & cancer.

Identification of a putative molecular subtype of adult-type diffuse astrocytoma with recurrent MAPK pathway alterations

D. Schrimpf, A. Vicha, A. Korshunov, 2024, Acta neuropathologica.